Skip to main content

Table 2 Total and differential cell counts in sputum of asthmatic and control patients.

From: Expression of ADAMs and Their Inhibitors in Sputum from Patients with Asthma

  Patients with asthma Control subjects
Sputum weight, g 4.35 (1.43–8.92) 3 (0.75–6.74)
Viability, % 92 (77–100) 92 (71–100)
Squamous cells, % 10 (0–33) 5 (0–13)
Total nonsquamous cell, × 103/g 1150 (260–25390) 1457 (150–2180)
Macrophages, % 41.6 (4–83)a 59.8 (25–76.4)
Macrophages, × 103/g 550 (85–5388) 761 (334–1513)
Eosinophils, % 5.2 (0–67)a 0.2 (0–7.2)
Eosinophils, × 103/g 59 (0–3555)a 2.1 (0–94)
Neutrophils, % 23.2 (1.4–80.6) 17 (5–55)
Neutrophils, × 103/g 343 (7–20464) 187 (42–1150)
Lymphocytes, % 1.8 (0–5.2)a 4.4 (0–13)
Lymphocytes, ×103/g 16 (0–196) 45 (0–170)
Epithelial cells, % 8 (1.4–48.4) 6.8 (1.8–33.2)
Epithelial cells (103/g) 145 (25–465) 131 (32–375)
  1. Data are expressed as median (range). aP < 0.05 vs. control subjects.